- Home
- ANGO vs JRI Comparison
ANGO vs JRI Comparison
Compare ANGO & JRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- JRI
- Stock Information
- Founded
- ANGO 1988
- JRI 2012
- Country
- ANGO United States
- JRI United States
- Employees
- ANGO N/A
- JRI N/A
- Industry
- ANGO Medical/Dental Instruments
- JRI Finance Companies
- Sector
- ANGO Health Care
- JRI Finance
- Exchange
- ANGO Nasdaq
- JRI Nasdaq
- Market Cap
- ANGO 400.8M
- JRI 377.5M
- IPO Year
- ANGO 2004
- JRI N/A
- Fundamental
- Price
- ANGO $12.02
- JRI $13.72
- Analyst Decision
- ANGO Strong Buy
- JRI
- Analyst Count
- ANGO 3
- JRI 0
- Target Price
- ANGO $19.33
- JRI N/A
- AVG Volume (30 Days)
- ANGO 435.9K
- JRI 68.0K
- Earning Date
- ANGO 10-02-2025
- JRI 01-01-0001
- Dividend Yield
- ANGO N/A
- JRI 9.38%
- EPS Growth
- ANGO N/A
- JRI N/A
- EPS
- ANGO N/A
- JRI N/A
- Revenue
- ANGO $300,718,000.00
- JRI N/A
- Revenue This Year
- ANGO $8.18
- JRI N/A
- Revenue Next Year
- ANGO $5.15
- JRI N/A
- P/E Ratio
- ANGO N/A
- JRI N/A
- Revenue Growth
- ANGO 2.73
- JRI N/A
- 52 Week Low
- ANGO $6.63
- JRI $9.70
- 52 Week High
- ANGO $13.50
- JRI $12.12
- Technical
- Relative Strength Index (RSI)
- ANGO 57.09
- JRI 41.26
- Support Level
- ANGO $11.53
- JRI $13.66
- Resistance Level
- ANGO $12.18
- JRI $13.83
- Average True Range (ATR)
- ANGO 0.37
- JRI 0.15
- MACD
- ANGO -0.07
- JRI -0.03
- Stochastic Oscillator
- ANGO 48.62
- JRI 10.29
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About JRI Nuveen Real Asset Income and Growth Fund of Beneficial Interest
Nuveen Real Asset Income and Growth Fund is the United States-based closed-end fund. Its objective is to provide a high level of current income and long-term capital appreciation. The fund invests a majority of its managed assets in equity and debt securities issued by real asset related companies located anywhere in the world. Its plan involves investments in five security types, infrastructure common stock, REIT preferred stock and debt securities. Real asset-related companies include those engaged in owning, operating, or developing infrastructure projects, facilities, and services, as well as REITs.